Modeling mitigation of influenza epidemics by baloxavir

Influenza viruses annually kill 290,000–650,000 people worldwide. Antivirals can reduce death tolls. Baloxavir, the recently approved influenza antiviral, inhibits initiation of viral mRNA synthesis, whereas oseltamivir, an older drug, inhibits release of virus progeny. Baloxavir blocks virus replic...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Zhanwei, Nugent, Ciara, Galvani, Alison P., Krug, Robert M., Meyers, Lauren Ancel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7265527/
https://www.ncbi.nlm.nih.gov/pubmed/32487990
http://dx.doi.org/10.1038/s41467-020-16585-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7265527/
https://www.ncbi.nlm.nih.gov/pubmed/32487990
http://dx.doi.org/10.1038/s41467-020-16585-y

Ejemplares similares